StonvexLoading…
StonvexStonvexStonvexCore line items from WTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-29 | Annual 2025 2025-12-31 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $731.64M | $677.30M | $2.44B | $1.81B | $1.20B |
Operating Income | Not available | $133.00M | $448.10M | $334.40M | $223.00M |
Net Income | Not available | $99.60M | $340.80M | $257.10M | $174.90M |
EPS (Diluted) | $3.35 | $2.97 | $10.17 | $7.67 | $5.22 |
Total Assets | Not available | $2.94B | $2.88B | $2.73B | $2.64B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $374.70M | $405.50M | $457.70M | $369.30M |
Free Cash Flow OCF − CapEx | Not available | $6.60M | $356.30M | $216.00M | $105.10M |
Shares Outstanding | Not available | 33.50M | 33.50M | 33.50M | 33.50M |